HAIC Plus Lenvatinib and PD-1 Antibody Versus HAIC Plus Lenvatinib for Advanced HCC

Clinical trial NCT03803254 · WITHDRAWN

Trial details

NCT number: NCT03803254
Sponsor: Sun Yat-sen University
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2019-01-03
Primary completion: 2021-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.